Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression
about
CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndromeUrocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptorsTopographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylaseIdentification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain.Stress-activated afferent inputs into the anterior parvicellular part of the paraventricular nucleus of the hypothalamus: Insights into urocortin 3 neuron activation.Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus.Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.Hypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats.Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNACorticotropin-releasing factor-related peptides, serotonergic systems, and emotional behaviorThe CRF system and social behavior: a review.Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health.Fos expression following regimens of predator stress versus footshock that differentially affect prepulse inhibition in ratsEffects of intra-PAG infusion of ovine CRF on defensive behaviors in Swiss-Webster miceA triple urocortin knockout mouse model reveals an essential role for urocortins in stress recoveryThe role of CRF and CRF-related peptides in the dark side of addiction.Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight.Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumptionPerifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge.Cross species association examination of UCN3 and CRHR2 as potential pharmacological targets for antiobesity drugsAltered maternal profiles in corticotropin-releasing factor receptor 1 deficient miceUrocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talkActivation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response.Central urocortin 3 administration decreases limited-access ethanol intake in nondependent miceCRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamineEffects of stresscopin on rat hypothalamic paraventricular nucleus neurons in vitro.Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain.The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stressAltered position of cell bodies and fibers in the ventromedial region in SF-1 knockout mice.The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia.Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.Oxytocin in the nucleus accumbens shell reverses CRFR2-evoked passive stress-coping after partner loss in monogamous male prairie voles.Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat.
P2860
Q24671910-6FCF5512-F861-437D-B830-35820719F1C3Q27011274-4D71E636-DF45-4340-ACE8-AD016A644855Q28567593-B1D459EB-29F9-4F7E-83A5-200A6B2B3F7EQ28569531-4ACF19E5-C2D5-455C-A0FE-8749B6001467Q28574974-AF3C0F2A-3B81-4AF0-B089-DF581453187BQ30300356-36C4A81F-EC75-4915-8714-2D332251E9E4Q30422882-95DD166F-8C40-4F4B-87D3-9F6317A047E4Q30423107-E1187171-6649-4A83-90B7-296D484BB22FQ30433300-1D733C3E-9C08-4D10-ADE5-B939000507E7Q30434209-216A1D7C-7FE2-4721-BBDC-C7C14B8AFD40Q30435221-A0CEA8C3-2947-43DD-BBEF-921034FC5526Q30448992-0DA196AB-D3E2-4C32-A1F4-8F07D8CFE4ECQ30453661-4C0D8D61-2A53-489F-A231-50AF35CA727EQ30457438-F63D734A-F3A6-46AB-971B-4999A05AD3EBQ30462223-D86F640A-2B06-4EB8-832D-08713DC956C5Q30471568-4CE1A35F-8104-4E37-BC19-EA916D4D7E16Q30475603-4B57D3C5-65EF-4A19-93C7-0D44CF43B59EQ30476985-9BD658D0-1A1F-4458-9BC3-2AD4E71F9117Q30484216-957051A9-9679-4779-8F1B-06430630284AQ30487401-C65A98D9-28D2-4213-A6BC-FE5B973BE45CQ30491437-EF3C6D27-8F65-4EB3-82A3-9B88AAFE7C2EQ30495006-77319D87-65A3-49A2-B1ED-BA06979C2DD2Q30502566-189092E6-D385-476D-A9E2-FAAC829F3719Q30524485-0B8CA5C2-5473-4E1F-9063-660F945628D0Q33267340-B4A92D1B-129E-4A75-A5D5-62B8D3E70EBBQ33276252-E5E3E015-3564-4903-A09A-190E3C9D0538Q33553871-1D5953B3-51D0-4D87-A3B4-9CD18DA5AEEBQ33600238-E2C04FF0-BD38-46E9-9DD8-0A21ADC47DA5Q34013102-30B622A9-9794-4D5B-AA92-B8760AABB23DQ34412317-D9D49773-21FB-45CD-9D94-3D76FE2E9EA7Q34510953-6BF8566A-EABB-404C-BC4B-C67D6D99BAD1Q34562384-3B9EA633-047D-4984-A63E-6A87E1889810Q35081542-2C19059B-308A-441A-AD6E-74595F075998Q35236877-A676268F-8AB0-4A0D-9D6F-96F395B410D9Q35545471-1B7F7CA6-FB6E-4EF8-82BF-45C817992F8EQ35757207-3359B409-B075-414C-BFB6-A1AE112933AAQ36207802-B15137E6-2FAE-4455-9BDF-61A6BD89BB84Q36390400-ED12CDB5-4099-4224-AB50-73CCD2BAABCDQ36421747-49165857-9E13-4B84-8D70-4044AD5E91E5Q36454356-8652CF0D-24F5-4EF7-8D8A-E3B5D446733C
P2860
Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression
description
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Februar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/02/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/02/01)
@nl
наукова стаття, опублікована в лютому 2002
@uk
مقالة علمية نشرت في فبراير 2002 حول موضوع: دماغ
@ar
name
Urocortin III-immunoreactive p ...... ing factor receptor expression
@ast
Urocortin III-immunoreactive p ...... ing factor receptor expression
@en
Urocortin III-immunoreactive p ...... ing factor receptor expression
@nl
type
label
Urocortin III-immunoreactive p ...... ing factor receptor expression
@ast
Urocortin III-immunoreactive p ...... ing factor receptor expression
@en
Urocortin III-immunoreactive p ...... ing factor receptor expression
@nl
prefLabel
Urocortin III-immunoreactive p ...... ing factor receptor expression
@ast
Urocortin III-immunoreactive p ...... ing factor receptor expression
@en
Urocortin III-immunoreactive p ...... ing factor receptor expression
@nl
P2093
P1476
Urocortin III-immunoreactive p ...... ing factor receptor expression
@en
P2093
Joan Vaughan
Paul E Sawchenko
Wylie W Vale
P304
P356
10.1523/JNEUROSCI.22-03-00991.2002
P407
P577
2002-02-01T00:00:00Z